Moderna said on Wednesday it would now operate full end-to-end manufacturing for its mRNA medicines in the U.S., marking a ...

CAMBRIDGE, MA / ACCESSWIRE / May 2, 2023 /Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced plans to establish an ...

New capabilities strengthen U.S. production, completing Moderna's domestic end-to-end mRNA manufacturing network More than ...

For the longest time, Moderna was an early-stage biotech with much promise but a long path to market. The advent of COVID-19 in 2020, however, changed all that, pole-vaulting the company into the ...

Moderna announced Tuesday that it has hired Chantal Friebertshäuser as SVP of commercial for Europe, the Middle East and Canada. Most recently, Friebertshäuser served in global commercial leadership ...

As Moderna awaits the arrival of the commercial COVID-19 vaccine market in the U.S., the toll of waning demand worldwide has become painfully apparent. For all of 2022, the mRNA specialist logged a $1 ...

Newly created role will have responsibility for commercial efforts in Europe, Middle East and Canada CAMBRIDGE, MA / ACCESSWIRE / December 20, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology ...

CAMBRIDGE, MA / ACCESSWIRE / April 27, 2022 / Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Arpa Garay will join ...

Corinne Le Goff has been appointed president, CEO and director at Celsion, the clinical-stage biotech announced. Michael Tardugno, the company’s former president and CEO, will continue to serve as ...

The Enterprise Solutions Hub in the Philippines will support the Asia Pacific region and complements Moderna's Enterprise Solutions Hubs in Warsaw, Poland, and Atlanta, U.S. The Philippines was ...